Carbamoylphosphonate matrix metalloproteinase inhibitors 6: cis-2-aminocyclohexylcarbamoylphosphonic acid, a novel orally active antimetastatic matrix metalloproteinase-2 selective inhibitor--synthesis and pharmacodynamic and pharmacokinetic analysis.
@article{Hoffman2008CarbamoylphosphonateMM, title={Carbamoylphosphonate matrix metalloproteinase inhibitors 6: cis-2-aminocyclohexylcarbamoylphosphonic acid, a novel orally active antimetastatic matrix metalloproteinase-2 selective inhibitor--synthesis and pharmacodynamic and pharmacokinetic analysis.}, author={A. Hoffman and Bashir Qadri and Julia Frant and Yiffat Katz and S. R. Bhusare and E. Breuer and R. Hadar and R. Reich}, journal={Journal of medicinal chemistry}, year={2008}, volume={51 5}, pages={ 1406-14 } }
cis-2-Aminocyclohexylcarbamoylphosphonic acid ( cis-ACCP) was evaluated in vitro and in two in vivo cancer metastasis models. It reduced metastasis formation in mice by approximately 90% when administered by a repetitive once daily dosing regimen of 50 mg/kg via oral or intraperitoneal routes and was nontoxic up to 500 mg/kg, following intraperitoneal administration daily for two weeks. Pharmacokinetic investigation of cis-ACCP in rats revealed distribution restricted into the extracellular… CONTINUE READING
Figures, Tables, and Topics from this paper
33 Citations
Orally Active, Antimetastatic, Nontoxic Diphenyl Ether‐Derived Carbamoylphosphonate Matrix Metalloproteinase Inhibitors
- Chemistry, Medicine
- ChemMedChem
- 2011
- 12
Carbamoylphosphonates control tumor cell proliferation and dissemination by simultaneously inhibiting carbonic anhydrase IX and matrix metalloproteinase-2. Toward nontoxic chemotherapy targeting tumor microenvironment.
- Chemistry, Medicine
- Journal of medicinal chemistry
- 2012
- 16
N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity.
- Chemistry, Medicine
- Journal of medicinal chemistry
- 2015
- 30
Aminoalkylcarbamoylphosphonates reduce TNFα release from activated immune cells.
- Chemistry, Medicine
- Bioorganic & medicinal chemistry letters
- 2010
- 5
Dual targeting of cancer-related human matrix metalloproteinases and carbonic anhydrases by chiral N-(biarylsulfonyl)-phosphonic acids
- Chemistry, Medicine
- Journal of enzyme inhibition and medicinal chemistry
- 2017
- 5
- PDF
Synthesis and biological evaluation in U87MG glioma cells of (ethynylthiophene)sulfonamido-based hydroxamates as matrix metalloproteinase inhibitors.
- Chemistry, Medicine
- European journal of medicinal chemistry
- 2011
- 24
Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.
- Chemistry, Medicine
- Bioorganic & medicinal chemistry
- 2008
- 65
References
SHOWING 1-10 OF 31 REFERENCES
Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.
- Chemistry, Medicine
- Journal of medicinal chemistry
- 2004
- 35
Carbamoylphosphonate Matrix Metalloproteinase Inhibitors 3: In vivo Evaluation of Cyclopentylcarbamoylphosphonic Acid in Experimental Metastasis and Angiogenesis
- Biology, Medicine
- Clinical Cancer Research
- 2005
- 21
- PDF
Carbamoylphosphonate-based matrix metalloproteinase inhibitor metal complexes: solution studies and stability constants. Towards a zinc-selective binding group
- Chemistry, Medicine
- JBIC Journal of Biological Inorganic Chemistry
- 2004
- 41
Pharmacodynamic and pharmacokinetic rationales for the development of an oral controlled-release amoxicillin dosage form.
- Medicine
- Journal of controlled release : official journal of the Controlled Release Society
- 1998
- 37
A phase II and pharmacological study of the matrix metalloproteinase inhibitor (MMPI) COL-3 in patients with advanced soft tissue sarcomas
- Medicine
- Investigational New Drugs
- 2006
- 37
Phase I clinical trial of oral COL-3, a matrix metalloproteinase inhibitor, in patients with refractory metastatic cancer.
- Medicine
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- 2001
- 148
Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug
- Chemistry, Medicine
- Nature Biotechnology
- 2007
- 947
The design, structure, and clinical update of small molecular weight matrix metalloproteinase inhibitors.
- Chemistry, Medicine
- Current medicinal chemistry
- 2004
- 167